Table 13:
Procedural Costs Used in the Cost-Effectiveness Models
| Cost-Effectiveness Analysis (RCT) | Resource | Costs (2016 CAD) | |
|---|---|---|---|
| TAVI | SAVR | ||
| Tam et al, 201816 (PARTNER 2) |
Valve | 24,000 | 6,000 |
| Index hospitalization stay | 10,102 | 17,369 | |
| Surgeon, surgical assistant, anesthesiologist fees | 3,737 | 4,253 | |
| Total procedural costsa | 40,274 | 29,856 | |
| Tam et al, 201817 (SURTAVI) |
Valve | 22,000 | 6,000 |
| Index hospitalization stay | 9,866 | 15,357 | |
| Surgeon, surgical assistant, anesthesiologist fees | 2,836 | 3,549 | |
| Total procedural costsa | 39,753 | 27,918 | |
Abbreviations: RCT, randomized controlled trial; SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation.
a
Includes valve, index hospitalization stay, and fees, plus an estimate of costs for periprocedural complications (not provided in the original publications).